Evidence map›Paper›PMID 28733929›Full record

ArticleInternational ophthalmology2018

Outcomes of Ahmed glaucoma valve implantation for steroid-induced elevated intraocular pressure in patients with retinitis pigmentosa.

Umit Eksioglu, Caglar Oktem, Gulten Sungur, Mehmet Yakin, Gulizar Demirok, Firdevs Ornek

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Umit EksiogluDepartment of Ophthalmology, Ankara Training and Research Hospital, Goz Poliklinigi, 06340, Altindag, Ankara, Turkey.
Caglar OktemManavgat State Hospital, Manavgat, Antalya, Turkey.
Gulten SungurDepartment of Ophthalmology, Ankara Training and Research Hospital, Goz Poliklinigi, 06340, Altindag, Ankara, Turkey.
Mehmet YakinDepartment of Ophthalmology, Ankara Training and Research Hospital, Goz Poliklinigi, 06340, Altindag, Ankara, Turkey. yakinmehmet@hotmail.com.ORCID http://orcid.org/0000-0002-3470-4124
Gulizar DemirokDepartment of Ophthalmology, Ankara Training and Research Hospital, Goz Poliklinigi, 06340, Altindag, Ankara, Turkey.
Firdevs OrnekDepartment of Ophthalmology, Ankara Training and Research Hospital, Goz Poliklinigi, 06340, Altindag, Ankara, Turkey.
Ministry of Health · TRSivas State Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the outcomes of Ahmed glaucoma valve (AGV) in the management of elevated intraocular pressure (IOP) secondary to steroid use for macular edema in patients with retinitis pigmentosa (RP).

methodsA total of nine eyes of five patients were evaluated retrospectively. Complete success was defined as IOP ≤ 21 mmHg without glaucoma medications, while qualified success was defined as IOP ≤ 21 mmHg with glaucoma medications.

resultsMean age at surgery was 25.0 ± 8.3 years, and mean follow-up time was 38.4 ± 13.2 months. Mean IOP was 41.0 ± 8.3 mmHg preoperatively, 9.4 ± 3.5 mmHg at first week (p = 0.008), 13.1 ± 3.6 mmHg at first month (p = 0.008), 14.8 ± 4.1 mmHg at 6th month (p = 0.008), 11.7 ± 2.6 mmHg at 12th month (p = 0.008), 12.4 ± 2.9 mmHg at 24th month (p = 0.008), 12.6 ± 3.6 mmHg at 36th month (p = 0.043) and 12.8 ± 4.2 mmHg at 48th month (p = 0.068) postoperatively. The mean number of topical anti-glaucomatous medications decreased from 2.8 ± 0.4 preoperatively to 0.4 ± 0.9 postoperatively (p = 0.007). Complete success was obtained in 7 (77%) eyes, and qualified success in 2 (23%) eyes. No failure was detected.

conclusionsAGV implantation can be considered as an alternative and safe option in the management of resistant, elevated IOP secondary to steroid treatment for macular edema in patients with RP.

Indexed as

Glaucoma Drainage ImplantsVisual AcuityAdolescentAdultChildDrug Administration RoutesFemaleFiltering SurgeryFollow-Up StudiesGlaucomaGlucocorticoidsHumansIntraocular PressureMalePostoperative PeriodRetinitis PigmentosaGlucocorticoidsAhmed glaucoma valveMacular edemaRetinitis pigmentosaSteroid-induced intraocular pressure elevation

Identifiers

PMID28733929
OpenAlexW2737157613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.